Bischoff M, Berger-Bächi B
Institute of Medical Microbiology, University of Zürich, CH8028 Zürich, Switzerland.
Antimicrob Agents Chemother. 2001 Jun;45(6):1714-20. doi: 10.1128/AAC.45.6.1714-1720.2001.
A natural rsbU mutant of Staphylococcus aureus, unable to activate the alternative transcription factor sigma(B) via the RsbU pathway and therefore forming unpigmented colonies, produced first-step teicoplanin-resistant mutants upon selection for growth in the presence of teicoplanin, of which the majority were of an intense orange color. By using an asp23 promoter-luciferase fusion as an indicator, the pigmented mutants were shown to express increased sigma(B) activity. Increased sigma(B) activity was associated with point mutations in rsbW, releasing sigma(B) from sequestration by the anti-sigma factor RsbW, or to promoter mutations increasing the sigma(B)/RsbW ratio. Genetic manipulations involving the sigB operon suggested that the mutations within the operon were associated with the increase in teicoplanin resistance. The upregulation of sigma(B) suggests that a sigma(B)-controlled gene(s) is directly or indirectly involved in the development of teicoplanin resistance in S. aureus. Carotenoids do not contribute to teicoplanin resistance, since inactivation of the dehydrosqualene synthase gene crtM abolished pigment formation without affecting teicoplanin resistance. The relevant sigma(B)-controlled target genes involved in teicoplanin resistance remain to be identified.
金黄色葡萄球菌的一种天然rsbU突变体,无法通过RsbU途径激活替代转录因子sigma(B),因此形成无色素菌落,在替考拉宁存在下选择生长时产生了第一步耐替考拉宁突变体,其中大多数为深橙色。通过使用asp23启动子-荧光素酶融合作为指标,发现有色素的突变体表达增加的sigma(B)活性。增加的sigma(B)活性与rsbW中的点突变有关,使sigma(B)从抗sigma因子RsbW的隔离中释放出来,或与增加sigma(B)/RsbW比率的启动子突变有关。涉及sigB操纵子的基因操作表明,操纵子内的突变与替考拉宁耐药性的增加有关。sigma(B)的上调表明一个受sigma(B)控制的基因直接或间接参与了金黄色葡萄球菌中替考拉宁耐药性的发展。类胡萝卜素对替考拉宁耐药性没有贡献,因为脱氢鲨烯合酶基因crtM的失活消除了色素形成而不影响替考拉宁耐药性。参与替考拉宁耐药性的相关受sigma(B)控制的靶基因仍有待确定。